Cargando…
Recent advances and developments in COVID‐19 in the context of allergic diseases
BACKGROUND: Since the first reports of coronavirus disease 2019 (COVID‐19) in Wuhan, China, in December 2019, there have been 198 million confirmed cases worldwide as of August 2021. The scientific community has joined efforts to gain knowledge of the newly emerged virus named severe acute respirato...
Autores principales: | Ding, Mei, Dong, Xiang, Sun, Yuan‐li, Sokolowska, Milena, Akdis, Mübeccel, van de Veen, Willem, Azkur, Ahmet Kursat, Azkur, Dilek, Akdis, Cezmi A., Gao, Ya‐dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646609/ https://www.ncbi.nlm.nih.gov/pubmed/34582102 http://dx.doi.org/10.1002/clt2.12065 |
Ejemplares similares
-
Recent developments in the immunopathology of COVID‐19
por: Zhang, Huan‐ping, et al.
Publicado: (2022) -
Nature of Regulatory T Cells in the Context of Allergic Disease
por: Ozdemir, Cevdet, et al.
Publicado: (2008) -
Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
por: Akdis, Cezmi A, et al.
Publicado: (2015) -
Schmallenberg virus induces apoptosis in Vero cell line via extrinsic and
intrinsic pathways in a time and dose dependent manner
por: AKSOY, Emel, et al.
Publicado: (2018) -
Involvement and therapeutic implications of airway epithelial barrier dysfunction in type 2 inflammation of asthma
por: Dong, Xiang, et al.
Publicado: (2022)